Modern Pathology

FIGURE 2

FROM:

IMP-3 is a novel progression marker in malignant melanoma

Jennifer G Pryor, Patricia A Bourne, Qi Yang, Betsy O Spaulding, Glynis A Scott and Haodong Xu

BACK TO ARTICLE

Figure 2.

Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

IMP-3 immunohistochemistry showing (a) weak cytoplasmic expression in the dermal component of a Spitz nevus and (b) strong cytoplasmic expression in metastatic melanoma. Compared to (c) patchy IMP-3 expression in a malignant melanoma with a Breslow depth less than or equal to1 mm, (d) malignant melanoma with a Breslow depth >1 mm expresses IMP-3 in >90% of tumor cells. Note the IMP-3 expression in the hair follicle in part (c) (original magnification times 400: a, b; times 200: c, d).

BACK TO ARTICLE